Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP)

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e844-e846. doi: 10.1111/jdv.16735. Epub 2020 Jun 29.

Authors

F Koch¹, K A Salva¹, M Wirtz², E Hadaschik¹, R Varaljai¹, D Schadendorf¹, A Roesch¹

Affiliations

¹ Department of Dermatology, University Hospital of Essen, University Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany.
² SanaSkin, Zürich, Switzerland.

PMID: 32531115
DOI: 10.1111/jdv.16735

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Diclofenac / therapeutic use
Gels / therapeutic use
Humans
Keratosis, Actinic* / drug therapy
Plasma Gases* / therapeutic use
Prospective Studies
Treatment Outcome

Substances

Anti-Inflammatory Agents, Non-Steroidal
Gels
Plasma Gases
Diclofenac